Published in Medical Letter on the CDC and FDA, October 12th, 2003
The approval of Cubicin is part of FDA's ongoing efforts to help bring new types of antibiotics to patients to make sure there are treatment...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA